Embecta Corp
Veridion Score
BETAMEDIUM CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is EMBC moving today?
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
EMBC overview
Related filings and maps
Congress activity in EMBC
No receipt-qualified Congressional disclosure is present for EMBC in the cached public ledger.
EMBC contract awards, year to date.
Public federal awards linked to this ticker.
EMBC lobbying filings, year to date.
Registered lobbying filings matched to Embecta Corp.